Showing results (11-20 of 483) with videos related to
Sort By:
Pageof 49
Thrombosis Research|February 15, 1990
Platelet kinetics in patients with atherosclerosisH Sinzinger, I Virgolini, P FitschaJournal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1994
Synergistic antiplatelet action of nitric oxide (NO) with PGD2 and its metabolite PGJ2--relevance for cerebral circulation?M Rodrigues, P Fitscha, H SinzingerAgents and Actions. Supplements|January 1, 1997
Antimitotic actions of vasodilatory prostaglandins--clinical aspectsH Sinzinger, P Fitscha, H KritzThrombosis Research|March 1, 1990
Decreased prostaglandin-I2 stability in acute myocardial infarctionH Sinzinger, P Fitscha, B TisoThrombosis Research|March 8, 2000
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markersI Schweeger, P Fitscha, H SinzingerFolia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
The platelet rebound phenomenon during PGI2-infusion occurs at the receptor levelG Steurer, P Fitscha, H SinzingerWiener Klinische Wochenschrift|October 2, 1981
[Influence of the venous wall--platelet interaction by dihydroergotamine (author's transl)]K Silberbauer, P Fitscha, H SinzingerThe Journal of International Medical Research|January 1, 1988
Platelet deposition on human atherosclerotic lesions is decreased by low-dose aspirin in combination with dipyridamoleH Sinzinger, J O'Grady, P FitschaProstaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J KalimanAngiology|February 1, 1986
Platelet half-life, plasma thromboxane B2 and circulating endothelial-cells in peripheral vascular diseaseH Sinzinger, P Fitscha, B A PeskarPageof 49